Cite
HARVARD Citation
Favale, A. et al. (n.d.). P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab. Journal of Crohn's and colitis. p. S465. [Online].